Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;28(9):1178-1186.
doi: 10.1038/s41431-020-0640-x. Epub 2020 May 18.

Quality of life drives patients' preferences for secondary findings from genomic sequencing

Collaborators, Affiliations

Quality of life drives patients' preferences for secondary findings from genomic sequencing

Chloe Mighton et al. Eur J Hum Genet. 2020 Sep.

Abstract

There is growing impetus to include measures of personal utility, the nonmedical value of information, in addition to clinical utility in health technology assessment (HTA) of genomic tests such as genomic sequencing (GS). However, personal utility and clinical utility are challenging to define and measure. This study aimed to explore what drives patients' preferences for hypothetically learning medically actionable and non-medically actionable secondary findings (SF), capturing clinical and personal utility; this may inform development of measures to evaluate patient outcomes following return of SF. Semi-structured interviews were conducted with adults with a personal or family cancer history participating in a trial of a decision aid for selection of SF from genomic sequencing (GS) ( www.GenomicsADvISER.com ). Interviews were analyzed thematically using constant comparison. Preserving health-related and non-health-related quality of life was an overarching motivator for both learning and not learning SF. Some participants perceived that learning SF would help them "have a good quality of life" through informing actions to maintain physical health or leading to psychological benefits such as emotional preparation for disease. Other participants preferred not to learn SF because results "could ruin your quality of life," such as by causing negative psychological impacts. Measuring health-related and non-health-related quality of life may capture outcomes related to clinical and personal utility of GS and SF, which have previously been challenging to measure. Without appropriate measures, generating and synthesizing evidence to evaluate genomic technologies such as GS will continue to be a challenge, and will undervalue potential benefits of GS and SF.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Proposed relationship between personal utility, clinical utility, and quality of life.
Personal utility overlapped with clinical utility, suggesting that these concepts lie on a continuum. Examples of actions described by participants are placed along the continuum. QOL encompassed all of the dimensions of personal and clinical utility.

References

    1. Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:249–55. doi: 10.1038/gim.2016.190. - DOI - PubMed
    1. Wilson BJ, Miller FA, Rousseau F. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing. J Clin Epidemiol. 2017;92:4–6. doi: 10.1016/j.jclinepi.2017.08.018. - DOI - PubMed
    1. Phillips KA, Deverka PA, Sox HC, Khoury MJ, Sandy LG, Ginsburg GS, et al. Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research. Genet Med. 2017;19:1081–91. doi: 10.1038/gim.2017.21. - DOI - PMC - PubMed
    1. Ungar W. Next generation sequencing and health technology assessment in autism spectrum disorder. J Can Acad Child Adolesc Psychiatry. 2015;24:123–7. - PMC - PubMed
    1. Bombard Y, Bach PB, Offit K. Translating genomics in cancer care. J Natl Compr Cancer Netw. 2013;11:1343–53. doi: 10.6004/jnccn.2013.0158. - DOI - PubMed

Publication types